Castellanos SJL, Díaz GLM

Language: Spanish
References: 51
Page: 116-125
PDF size: 138.07 Kb.

ABSTRACT

In medicine and dentistry, customary practice has evolved from treating local and systemic diseases as separate concepts to accepting the possibility of bidirectionality, where mutual effects, be they beneficial or harmful, are apparent between the two. Bidirectionality acknowledges that the effect of local and general processes may be two-way (i.e., synergetic); that the pathogenic development of each can be independent or similar and come together or appear at specific moments (parallel development). The third option is that one is a manifestation of the other (causation). In the future, when the interface between medicine and dentistry and vice versa is better understood and more widely accepted, and the related prejudices and preconceptions disappear, this third type of association may prove to be that accepted as the standard concept, given that the causal relationship can accommodate not only the various branches of medicine, but also psychological, environmental, and social aspects, all involving a deterministic action as regards health and, more importantly, well-being. The causal relationship improves on the prevailing notion of bidirectionality in the sense that the latter continues to be grounded in the conceptualization of the distinct subdivisions of dentistry and medicine. In years to come, this causal relationship will make it evident that holistic medicine is merely an interacting part of a complex scenario in which elements other than just the biological ones, such as physical, mental, emotional, and economic factors, play a role, so broadening the concept of health that prevails today. Furthermore, a selection of information and reflections is presented on the interface between periodontology (the study of inflammatory periodontal conditions) and a number of cardiovascular processes and diseases, such as atherosclerosis, arterial hypertension, and ischemic disorders (infarction, angina). This presentation is accompanied by tables containing information relating to the preservation of the state of health of patients prone to developing cardiovascular disorders and conditions (salutogenesis).

REFERENCES

1. Offenbacher S, O’Reilly JPG, Wells SR, Salvi GE, Lawrence SS, Socransky SS, Beck JD. Potential pathogenic mechanisms of periodontitis–associated pregnancy complications. Ann Periodontol. 1998; 3: 233-350.

2. Castellanos JL, Díaz GL. Frecuencia de periodontitis crónica asociada a padecimientos sistémicos en 2000 pacientes. Revista ADM. 2002; 59: 122-127.

3. Nesse W, Dijkstra PU, Abbas F, Spijkervet FK, Stijger A, Tromp JA, van Dijk JL, Vissink A. Increased prevalence of cardiovascular and autoimmune diseases in periodontitis patients: a cross-sectional study. J Periodontol. 2010; 81: 1622-1628.

4. Holmlund A, Holm G, Lind L. Number of Teeth as a predictor of cardiovascular mortality in a cohort of 7,674 subjects followed for 12 years. J Periodontol. 2010; 81: 870-876.

5. Jansson L, Lavstedt S, Frithiof L. Relationship between oral health and mortality rate. J Clin Periodontol. 2002; 29: 1029–1034.

6. Elangovan S, Nalliah R, Allareddy V, Karimbux NY, Allareddy V. Outcomes in Patients Visiting Hospital EDs due to periodontal conditions in United States. J Periodontol. 2011; 82: 809-19.

7. Pizzo G, Guiglia R, Lo Russo L, Campisi G. Dentistry and internal medicine: from the focal infection theory to the periodontal medicine concept. Eur J Intern Med. 2010; 21: 496-502.

8. Lagervall M, Jansson L, Bergström J. Systemic disorders in patients with periodontal disease. J Clinl Periodontol. 2003; 30: 293–299.

9. Castellanos JL, Díaz GL, Gay ZO. Series en medicina bucal VI. Hiposalivación por fármacos. Manejo dental. Revista Asoc. Dental Mex. 2004; 61: 39-40.

10. Castellanos JL, Díaz GL, Gay ZO. Series en Medicina Bucal III. Manejo del paciente radiado en Odontología. Revista Asoc. Dental Mex. 2003; 60: 160-161.

11. US Department of Health and Human Services: Oral Health in America: A report of the Surgeon General. Rockville, MD: Department of health and human services, National Institute of Dental and Craniofacial Research, National Institutes of Health; 2000.

12. Paquette DW. The periodontal infection-systemic disease link: a review of the truth or myth. J Int Acad Periodontol. 2002; 4: 101-109.

13. González BA, Hosoya KS. Periodoncia. Capítulo 22. En: Castellanos JL, Díaz GL, Gay ZO. Medicina en Odontología. 2ª edición. México: El Manual Moderno; 2002.

14. Page RC. The pathobiology of periodontal diseases may affect systemic diseases: Inversion of a paradigm. Ann Periodontol. 1998; 3: 108-120.

15. Geerts S, Nys m, De Mol P et al. Systemic Release of Endotoxins Induced by Gentle Mastication: Assotiation With Periodontal Severity. J Periodontol. 2002;73:73-78.

16. Listgarten MA, Loomer PM. Microbial Identification in the Management of Periodontal Diseases. A Systematic Review. Ann Periodontol. 2003;8:182-192.

17. Song Y, Kozarov EV, Walters SM, Cao SL, Handfield M, Hillman JD, Progulske-Fox A. Genes of Periodontopathogens Expressed During Human Disease. Ann Periodontol. 2002:7:38-42.

18. Choi B, Park S, Yoo Y, Choi S, Chai Y, Cho K, Kim C. Detection of Major Putative Periodontopathogens in Korean Advanced Adult Periodontitis Patients Using a Nucleic Acid-Based Approach. J Periodontol. 2000; 9:1387-1394.

19. Kinane DF, Lappin DF. Immune Processes in Periodontal Disease: A Review. Ann Periodontol. 2002;7: 62-71.

20. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect. 2007; 4: 3-10.

21. Castellanos JL, Díaz GL. Embarazo, enfermedades sistémicas de alto riesgo y enfermedad periodontal. Perinatol Reprod Hum. 2009; 23: 64-72.

22. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease: a review. J Clin Periodontol. 2003; 30: 761–772.

23. Andreoli TE, Bennett JC, Carpenter CJ, Plum F. Compendio de Medicina Interna. 4ª Ed. México: McGraw Hill; 1999.

24. Ridker PM, Silvertown JD. Inflammation, C-Reactive protein, and Atherothrombosis. J Periodontol. 2008; 79: 1544-1551.

25. Ford PJ, Yamazaki K, Seymour GJ. Cardiovascular and oral disease interactions: what is the evidence? Prim Dent Care. 2007;14:59-66.

26. Vieira CL, Cury PR, Miname MH, Martinez LR, Bortolotto LA, Giuliano I, Santos RD, Caramelli B. Severe periodontitis is associated with diastolic blood pressure elevation in individuals with heterozygous familial hypercholesterolemia: a pilot study. J Periodontol. 2010. Poste don line. J Periodontol. 2011; 82: 683-8.

27. Tsakos G, Sabbah W, Hingorani AD, Netuveli G, Donos N, Watt RG , D´Aiuto F. Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. J Hypertense. 2010; 28: 2386-93.

28. Türkoğlu O, Barış N, Kütükçüler N, Şenarslan O, Güneri S, Atilla G. Evaluation of serum anti-cardiolipin and oxidized low-density lipoprotein levels in chronic periodontitis patients with essential hypertension. J Periodontol. 2008; 79: 332-340.

29. Vidal F, Figueredo CM, Cordovil I, Ricardo G, Fischer RG. Periodontal therapy reduces plasma levels of interleukin-6, c-reactive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol. 2009; 80: 786-791.

30. Cotti E, Dessì C, Piras A, Mercuro G. Can a chronic dental infection be considered a cause of cardiovascular disease? A review of the literature. Int J Cardiol [internet]. 2010[Access September 17] Int J Cardiol 2011; 148: 4-10.

31. Carallo C, Fortunato L, de Franceschi MS, Irace C, Tripolino C, Cristofaro MG, Giudice M, Gnasso A. Periodontal disease and carotid atherosclerosis: are hemodynamic forces a link? Atherosclerosis. 2010; 213: 263-267.

32. Cairo F, Nieri M, Gori AM, Rotundo R, Castellani S, Abbate R, Pini-Prato GP. Periodontal variables may predict sub-clinical atherosclerosis and systemic inflammation in young adults. A cross-sectional study. Eur J Oral Implantol. 2009; 2: 125-133.

33. Persson GR, Persson RE. Cardiovascular disease and periodontitis: an update on the associations and risk. J Clin Periodontol. 2008; 35 (Suppl): 362-379.

34. Bizzarro S, Nicu EA, van der Velden U, Laine ML, Loos BG. Association of serum immunoglobulin G (IgG) levels against two periodontal pathogens and prothrombotic state: a clinical pilot study. Thromb J. 2010; 4: 8-16.

35. Dorn JM, Genco RJ, Grossi SG, Falkner KL, Hovey KM, Iacoviello L, Trevisan M. Periodontal disease and recurrent cardiovascular events in survivors of myocardial infarction (MI): the western New York Acute MI Study. J Periodontol. 2010; 81: 502-511.

36. Mustapha IZ, Debrey S, Oladubu M, Ugarte R. Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol. 2007; 78: 2289-2302.

37. Monteiro AM, Jardini A, Alves S, Giampaoli V, Aubin EC, Figueiredo-Neto AM, Gidlund M. Cardiovascular Disease Parameters in Periodontitis. J Periodontol. 2010; 80: 378-388.

38. Mattila KJ, Pussinen PJ, Paju S. Dental infections and cardiovascular diseases: a review. J Periodontol. 2005; 76: 2085-2088.

39. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P,Offenbacher S et al. The American Journal of Cardiology and Journal of Periodontology Editors Consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009; 80: 1021-1032.

40. Castellanos JL, González S. Frecuencia de lesiones bucales en tabaquismo activo por cigarrillos. Rev Asoc Dental Mex. 1991; 48: 269-272.

41. Seymour RA, Preshaw PM, Thomason JM, Ellis JS, Steele JG. Cardiovascular diseases and periodontology. J Clinical Periodontol. 2003; 30: 279–292.

42. Díaz L, Castellanos JL. Radio internacional normalizado (RIN). Manejo dental de pacientes que reciben anticoagulantes orales. Revista Asoc Dental Mex. 1998; 55 (5): 242-246.

43. Díaz L, Castellanos JL. Trastornos de la hemostasia inducidos por el empleo de medicamentos. Medicina Oral. 1999; 4 (4): 552-563.

44. Brennan MT, Wynn RL, Miller CS. Aspirin and bleeding in dentistry: an update and Recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007; 104: 316-323.

45. Geerts S, Nys M, De Mol P et al. Systemic release of endotoxins induced by gentle mastication: association with periodontal severity. J. Periodontol. 2002; 73: 73-78.

46. Graziani F, Cei S, Tonetti M, Paolantonio M, Serio R, Sammartino G, Gabriele M, D´Aiuto F. Systemic inflammation following non-surgical and surgical periodontal therapy. J Clin Periodontol. 2010; 37: 848-854.

47. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol. 2008; 35: 277–290.

48. Foz MA, Romito RG, Bispo MC, Petrillo LC, Patel K, Suvan J, D´Aiuto F. Periodontal therapy and biomarkers related to cardiovascular risk. Minerva Stomatol. 2010; 59: 271-283.

49. Offenbacher S, Beck JD, Moss K, Mendoza L et al. Results from the periodontitis and vascular events (PAVE) study: a pilot multicentered, randomized, controlled trial to study effects of periodontal therapy in a secondary prevention model of cardiovascular disease. J Periodontol. 2009; 80: 190-201.

50. Tonetti MS. Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol. 2009; 36: 15-19.

51. The 6th European Workshop on Periodontology Contemporary Periodontics. Cardiovascular disease and periodontitis: an update on the associations and risk. J Clin Periodontol Special Issue. 2008; 35: 362–379.